Global Financial and Healthcare Updates: Credit Suisse AT1 Claims, AstraZeneca’s Cancer Breakthrough, German Gender Pay Gap, and Peace Prize Laureate
Key TakeawaysSingapore's Drew & Napier is set to file claims against the Swiss government, seeking approximately $300 million in compensation for 560 Asian bondholders impacted by the 2023 Credit Suisse AT1 debt wipeout, following a recent Swiss court ruling that deemed the write-down unlawful.AstraZeneca's (AZN) and Daiichi Sankyo's Datroway (datopotamab deruxtecan) has demonstrated a significant 5.0-month improvement in overall survival in aggressive triple-negative breast cancer (TNBC) patients, marking ...